A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer

A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer

Abstract Background Neoadjuvant endocrine therapy (NET) in oestrogen receptor-positive (ER+) /HER2-negative (HER2-) breast cancer allows real-time evaluation of drug efficacy as well as investigation of the biological and molecular changes that occur after estrogenic deprivation. Clinical and pathol...

Full description

Bibliographic Details
Main Authors: Joanna I. López-Velazco, Sara Manzano, María Otaño, Kepa Elorriaga, Núria Bultó, Julio Herrero, Ainhara Lahuerta, Virginia Segur, Isabel Álvarez-López, Maria M. Caffarel, Ander Urruticoechea
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Breast Cancer Research
Subjects:
Neoadjuvant endocrine therapy
Aromatase inhibitors
Tumour cellularity size
Oestrogen receptor (ER)-positive breast cancer
Pathological and radiological tumour response
Preoperative endocrine prognostic index (PEPI) score
Online Access:https://doi.org/10.1186/s13058-023-01756-8

Internet

https://doi.org/10.1186/s13058-023-01756-8

Similar Items